Research and experimental development on natural sciences and engineering
VIDUNDERLIG PHARMACEUTICALS AS
Revenue 2024
NOK 0
Operating profit
NOK 0
Equity
NOK 0
Incorporated
2022
Share capital
NOK 30,000
Organisation
Established
2022-08-20
Industry code
72.100
Legal form
AS
Group structure
Eier · 100.0%
Muisha Rodrig Shekobe Balingene
Company
VIDUNDERLIG PHARMACEUTICALS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikling av antistoff-legemiddel konjugat (ADC)- medisin mot HER2(reseptor tyrosine-protein kinase erbB-2), receptor tyrosine-protein kinase erbB-3(HER3) og Tumor-associated calcium signal transducer 2(TROP-2/TACSTD2) positiv brystkreft samt ADC-medisin mot myelomatose og mantle cell lymphom.
Business address
Falbes gate 18A, 0170 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.